ARCHIVES

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

This article is from The Cancer Letter archive.

Vol. 18 No. 37 | September 25, 1992

Download PDF Visit The Full Archive

Related Articles

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

November 1, 1985

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

NCI Signs Letters Of Intent With Latin American Countries

October 2, 2009